US-CHIMP · Novel User-friendly Ultrasound Methods for Monitoring and Prevention of Cerebral Hypoxia
Horizon Europe — Marie Skłodowska-Curie Actions
- Duration
- 2023-06-05 → 2025-06-04
- EU contribution
- €172,750
- Participants
- 1
- Scheme
- HORIZON-TMA-MSCA-PF-EF
Lines connect the coordinator with its partners.
Results in brief
Novel User-friendly Ultrasound Methods for Monitoring and Prevention of Cerebral Hypoxia
The US-CHIMP (Ultrasound Cerebral Hypoxia Imaging for Monitoring and Prevention) project addresses a critical healthcare challenge: the timely and accurate detection of cerebral hypoxia low oxygen levels in the brain, which can lead to permanent neurological damage. Cerebral hypoxia affects approximately half of critically ill patients but studying these conditions directly in intensive care settings is complicated due to patients' unstable health. Instead, US-CHIMP utilizes the unique environment of high-altitude exposure, where reduced oxygen levels naturally simulate conditions similar to clinical hypoxia, enabling safe investigation in healthy volunteers. Currently, the non-invasive techniques available to detect cerebral hypoxia either demand highly skilled personnel, involve significant observer variability, or lack clearly established diagnostic thresholds. There is an urgent need for accessible, user-friendly, and reliable tools to monitor and diagnose cerebral hypoxia effectively, particularly in challenging environments such as mountain rescue operations and remote healthcare settings. Ultrasound is portable and can be used in the field and at the bedside. The main goal of US-CHIMP is to develop a proof-of-concept ultrasound-based diagnostic method. This involves two primary innovative approaches: 1. Using 3D ultrasound imaging to measure the volume of the optic nerve sheath as an indirect marker of intracranial pressure, a critical indicator often linked to cerebral hypoxia. 2. Applying Wave Intensity Analysis (WIA) to the internal carotid and vertebral arteries to detect changes in cerebral blood flow dynamics as an indirect measure of brain oxygenation. The project comprises three core objectives: • Developing a reliable, semi-automated method for volumetric ultrasound assessment of the optic nerve sheath. • Establishing Wave Intensity Analysis techniques to characterize cerebral vascular changes due to hypoxia. • Validating these methods through controlled studies involving human volunteers exposed to simulated high-altitude conditions in the state-of-the-art environmental chamber.
Data: CORDIS, © European Union
Project objective
A lack of oxygen in the human brain (cerebral hypoxia) can result in permanent neuronal damage. Cerebral hypoxia is prevalent in half of all critical ill patients, but poor health impedes research in the intensive care unit. High-altitude exposure (>2500 m) is associated with a lower pressure of oxygen and offers a unique setting to investigate hypoxia-driven changes in otherwise healthy individuals. Unfortunately, at present, non-invasive methods to quantify surrogates of cerebral hypoxia are either laborious and require high-skilled personnel or have large inter-/intra-observer variability and no clear cut-off values. A user-friendly, unambiguous, and accessible diagnostic tool is urgently needed for the monitoring and decision-making in the field and at the beside. US-CHIMP (UltraSound Cerebral Hypoxia Imaging for Monitoring and Prevention) aims to provide a proof-of-concept by combining volumetric US to measure optic nerve sheath diameter as a surrogate of intracranial pressure with wave intensity analysis from the internal carotid and vertebral artery as a surrogate of changes in cerebral oxygen delivery. In three work packages US-CHIMP builds the theoretical groundwork through simulation (WP1/WP2) and the first practical proof-of-concept through translation in an experimental study (WP3) in which human volunteers are exposed to mild hypobaric hypoxia. WP3 is performed in the terraXcube, an extraordinary environmental chamber of the Institute of Mountain Emergency Medicine at Eurac Research. US-CHIMP will provide accurate information about key clinical syndromes. The data is directly relevant to the management of conditions related to high-altitude hypoxia. Besides, many clinical conditions such as intracranial haemorrhage, brain injury and stroke present with elevated intracanal pressures and altered cerebral haemodynamics. Their management will be supported by an accessible and reliable non-invasive bedside monitoring that US-CHIMP aims to provide.
Original text from CORDIS.
Participants
- ACCADEMIA EUROPEA DI BOLZANO · BolzanoCoordinatorItaly
Links
- View on CORDIS
- DOI: 10.3030/101105524
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e505db6540&appId=PPGMS
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e51c419d6c&appId=PPGMS
Data: CORDIS, © European Union
